Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Find Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Near You

A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a prospective study to assess the burden of existing or hidden cardiovascular (CV) and renal disease in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a Hong Kong public hospital setting. By implementing a chronic obstructive pulmonary disease (COPD) discharge care bundle with integrated CV/renal screening, the study aims to quantify undiscovered disease prevalence, evaluate risk factors for future exacerbations, and compare re-admission rates against historical controls, ultimately informing integrated cardiopulmonary management strategies.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• Age ≥40 years

• Patients hospitalized due to COPD exacerbation.

• Patients diagnosed with COPD, a confirmed COPD diagnosis with a specific FEV1/FVC ratio (\<0.70)

• Able to provide informed consent

Locations
Other Locations
Hong Kong Special Administrative Region
Prince of Wales Hospital
RECRUITING
Shatin
Contact Information
Primary
Fanny WS Ko, MD
fannyko@cuhk.edu.hk
85235053133
Backup
David SC Hui, MD
dschui@cuhk.edu.hk
85235053128
Time Frame
Start Date: 2026-01-15
Estimated Completion Date: 2029-02-28
Participants
Target number of participants: 150
Treatments
Experimental: Implementation of the COPD discharge care bundle
Prospective recruitment with implementation of the COPD discharge care bundle
Other: Historic controls
Historical records of prior acute exacerbation of COPD episodes and management under standard care from the database
Sponsors
Leads: Chinese University of Hong Kong

This content was sourced from clinicaltrials.gov